Our latest paper in Resuscitation picked up in an editorial by the journal

Our recent paper entitled ”Early recovery of frontal EEG slow wave activity during propofol sedation predicts outcome after cardiac arrest” (Resuscitation, Volume 165, 2021) has been picked up by an editorial published in the same journal.
The editorial inspired by our paper – and by our Cerenion C-Trend® technology used in conjunction with the Bittium BrainStatus™ system – looks at new advances in measuring and understanding EEG after cardiac arrest.
The editorial reports that present scientific knowledge is moving towards embracing EEG recording already in the first 12−24 h after cardiac arrest, instead of the old practice of recording EEG only 48–96 h after cardiac arrest. This is supported by several recent publications cited by the editorial, and by our own published research on the topic.
However, the above shift has been hindered by, for example, the fact that only 40% of all cardiac arrests occur during office hours, as noted by the editorial. The editorial also reports that even in centers where continuous EEG registration is well organized, it takes a mean of 11 h to start EEG recording, and after 12 h only about 50% of the patients are hooked onto EEG.
It is statistics such as these that we hope to change by bringing practical EEG into routine use at the ICU. Advancing the adoption of EEG by tackling the challenges related to both carrying out and analyzing the recordings is a driving motivation behind the long-term development of our C-Trend® technology.
About Resuscitation
Resuscitation is a monthly international and interdisciplinary medical journal. The papers published deal with the aetiology, pathophysiology and prevention of cardiac arrest, resuscitation training, clinical resuscitation, and experimental resuscitation research, although papers relating to animal studies will be published only if they are of exceptional interest and related directly to clinical cardiopulmonary resuscitation. Papers relating to trauma are published occasionally but the majority of these concern traumatic cardiac arrest. Recognised by the European Resuscitation Council as its official Journal. https://www.resuscitationjournal.com/
About Cerenion C-Trend®
Cerenion Oy has developed the world’s first practical method for measuring the brain function of intensive care patients. Cerenion's patented C-Trend® technology reveals the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient. The solution works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The technology has the potential of improving both the quality and the cost of intensive care.
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2023 Cerenion Oy